Artificial intelligence in haematologic diagnostics: Current applications and future perspectives [0.03%]
人工智能在血液学诊断中的应用及未来展望
Annatina Sarah Schnegg-Kaufmann,Ulrike Bacher,Alicia Rovó et al.
Annatina Sarah Schnegg-Kaufmann et al.
Clinical researchers and laboratory specialists are striving to explore artificial intelligence (AI) to facilitate and optimise haematological diagnostics in response to the growing demand for more efficient and accurate diagnoses. This rev...
Ponatinib Monotherapy in adult patients with Relapsed or Refractory Philadelphia-Positive Acute Lymphoblastic Leukemia: A Real-World Retrospective Analysis Including MRD Relapse [0.03%]
伊马替尼单药治疗复发或难治性Ph染色体阳性急性淋巴细胞白血病成人患者的真实世界回顾性分析(包括微小残留病复发)
Kyoung Il Min,Daehun Kwag,Gi June Min et al.
Kyoung Il Min et al.
Introduction: The treatment of relapsed or refractory (R/R) Philadelphia chromosome (Ph)-positive acute lymphoblastic leukemia (ALL) remains challenging after failure to several tyrosine kinase inhibitors. This study eval...
Establishment and Evaluation of Prognostic Prediction Model for Diffuse Large B-cell Lymphoma Patients Based on International Prognostic Index and FAT4, TP53 Mutation [0.03%]
基于国际预后指标和FAT4、TP53突变的弥漫性大B细胞淋巴瘤患者预后预测模型的建立及评估
Letian Shao,Zhen Kou,Renaguli Abulaiti et al.
Letian Shao et al.
Diffuse large B-cell lymphoma (DLBCL) is a common type of non-Hodgkin lymphoma with clinical and genetic heterogeneity, leading to significant differences in patient prognosis. In this study, a retrospective analysis was conducted on releva...
Real World Experience of Azacitidine + Venetoclax in AML rigorously following management guidelines from clinical trial [0.03%]
严格遵循临床试验管理指南的Azacytidine和Venetoclax治疗AML的现实世界经验
Bochra Sedaki,Alexandre Iat,Sami Benachour et al.
Bochra Sedaki et al.
Azacitidine + venetoclax is a new standard of care for acute myeloid leukemia not eligible for intensive chemotherapy. This combination is associated with hematological toxicities and some drug interactions. Real-world studies have shown a ...
Case report: Donor-derived clonal haematopoiesis after allogeneic stem cell transplantation [0.03%]
病例报告:allo-HSCT后的供者来源的克隆性造血
Adrian Schwarzer,Christian Späth,Thomas Neumann et al.
Adrian Schwarzer et al.
The accidental transmission of malignant and non-malignant hematological diseases through allogeneic hematopoietic cell transplantation has been described. Next-generation sequencing facilitates the detection of a wide range of mutations in...
Case Reports
Acta haematologica. 2025 Sep 18:1-13. DOI:10.1159/000548473 2025
Patient Characteristics and Outcomes of Nodular Lymphocyte Predominant Hodgkin Lymphoma at a Safety-Net System Compared to an Academic Comprehensive Cancer Center [0.03%]
安全网医院与学术型综合癌症中心的 nodular lymphocyte predominant hodgkin 淋巴瘤患者的临床特征和结局比较
Luise Froessl,Theo Sottero,L Steven Brown et al.
Luise Froessl et al.
Nodular lymphocyte-predominant Hodgkin's lymphoma often follows an indolent course but carries a risk of late recurrence and transformation. Given its rarity, there is significant variability in the treatment patterns at various healthcare ...
Paroxysmal nocturnal hemoglobinuria with large clones in non-hypoplastic myelodysplastic syndrome- report of two cases [0.03%]
非低增生性骨髓增生异常综合征中出现大克隆的阵发性睡眠型血红蛋白尿两例报告
Janine Briggeler-Mani,Emmanuel Häfliger,Annatina Sarah Schnegg-Kaufmann et al.
Janine Briggeler-Mani et al.
Paroxysmal Nocturnal Hemoglobinuria (PNH) clones are frequently found in hypoplastic myelodysplastic syndromes (hMDS), though less commonly than in aplastic anemia. In contrast, the coexistence of hemolytic PNH with large clones and classic...
Case Reports
Acta haematologica. 2025 Sep 8:1-13. DOI:10.1159/000548287 2025